MarshallJayGlesbyMDPhD

Infectious Disease • New York, NY

HIV/AIDS Medicine

Professor of Medicine, Weill Cornell Medical College

Join to view full profile

Dr. Glesby is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Glesby's full profile

Already have an account?

Office
525 E 68th St
# Baker
New York, NY 10065
Phone+1 212-746-7134

Fax+1 212-746-8852

Education & Training

Johns Hopkins UniversityFellowship, Infectious Disease, 1992 - 1996
Johns Hopkins UniversityResidency, Internal Medicine, 1989 - 1992
Johns Hopkins University School of MedicineClass of 1989

Certifications & Licensure

NY State Medical License 1997 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

Top Doctors: New York Metro Area Castle Connolly, 2013-2014
Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2012-2015
Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2012-2015

Clinical Trials

Interleukin-2 (IL-2), Pegylated Interferon (PEG-IFN Alfa-2b), and Ribavirin (RBV) Treatment in Patients With Hepatitis C and HIV Coinfection
Completed
Not Applicable
Interactions Between HIV Protease Inhibitors and Calcium Channel Blockers
Completed
Phase 1
Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance Start of enrollment: 2005 Mar 01
Completed
Phase 1, Phase 2
Anti-D for Treating Thrombocytopenia in Adults Infected With Hepatitis C Virus With or Without HIV Co-Infection Start of enrollment: 2005 Mar 01
Terminated
Phase 4
Pioglitazone Before Peginterferon and Ribavirin for Hepatitis C Infection in HIV/HCV-Coinfected Patients With Insulin Resistance Start of enrollment: 2009 Mar 01
Completed
Phase 2
Respiratory Virus Outpatient Study (FLU 002 Plus) Start of enrollment: 2009 Aug 01
Completed
Doxycycline for COPD in HIV-Infected Patients Start of enrollment: 2014 Dec 08
Completed
Not Applicable
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection Start of enrollment: 2014 May 30
Completed
Phase 1
Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive Antiretroviral Therapy (ART) Start of enrollment: 2015 Dec 21
Completed
Phase 1, Phase 2
PREPARE (A5361s) Substudy of REPRIEVE (A5332) Start of enrollment: 2017 Feb 28
Completed
A Trial of CONvalescent Plasma for Hospitalized Adults With Acute COVID-19 Respiratory Illness Start of enrollment: 2020 Jun 24
Recruiting
Phase 3
Doxycycline for Emphysema in People Living With HIV (The DEPTH Trial) Start of enrollment: 2022 Aug 22
Recruiting
Phase 2
Roles: Contact, Principal Investigator
A Study to Evaluate the Effects of Cenicriviroc Mesylate on Arterial Inflammation in People Living With HIV Start of enrollment: 2023 May 30
Active, not recruiting
Phase 2
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

25 citations
Current state of the art in rapid diagnostics for antimicrobial resistance
Rathina Kumar Shanmugakani, Balaji Vasan Srinivasan, Marshall J. Glesby, Lars F. Westblade, Washington B. Cárdenas
Lab on a Chip. 2020-07-28
37 citations
Factors associated with smoking in HIV-infected patients and potential barriers to cessation.
Daniel Shirley, Ravi K. Kesari, Marshall J. Glesby
AIDS Patient Care and Stds. 2013-11-05
90 citations
Clinical Spectrum of Herpes Zoster in Adults Infected with Human Immunodeficiency Virus
Marshall J. Glesby, Richard D. Moore, Richard E. Chaisson
Clinical Infectious Diseases. 1995-08-01

Journal Articles

Moderate Alcohol Use Is Not Associated with Fibrosis Progression in Human Immunodeficiency Virus/Hepatitis C Virus–Coinfected Women: A Prospective Cohort Study
Phyllis C Tien, Marshall J Glesby, Michael Augenbraun, Marion G Peters, Clinical Infectious Diseases

Lectures

CCR5 delta32 Cord & Haploidentical Grafts: Allogeneic Stem Cell Transplant for HIV+ /AML Patient: A Case Report from the Impaact P1107 Observational StudyClinically Re...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Other

Treatment of HIV-associated lipodystrophy
Glesby MJ
http://www.uptodate.com/contents/treatment-of-hiv-associated-lipodystrophy
UpToDate, Wolters Kluwer Health - 2012-10-05

Press Mentions

HIV Patients Fare Well with Mpox TreatmentMay 5th, 2023
NIH Grant Funds Antibiotic Trial for Patients with HIV and EmphysemaDecember 13th, 2022
How a Select Few People Have Been Cured of HIVOctober 5th, 2022
Join now to see all

Grant Support

Complications Of Chronic Viral InfectionsNational Institute Of Allergy And Infectious Diseases2008–2011
A5229 Lipoatrophy StudyNational Center For Research Resources2007
Study Of Safety And Efficacy Of Rhgh A/O Rosiglitazone In HIVNational Center For Research Resources2006–2007
Growth Hormone And Rosiglitazone For Visceral AdoposityNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2007
Suppressive Long-Term Antiviral Management Of HCV And HIV Coinfected SubjectsNational Center For Research Resources2005–2007
Growth Hormone And Rosiglitazone For Hiv-Associated LipodystrophyNational Center For Research Resources2005
A5127: PH II Trial/ Adefovir Dipivoxil/ Tenofovir Disoproxil Fumarate/ HEP B/ HNational Center For Research Resources2005
A5163: Phase II, Study Of Alendronate In HIV W/ Decreased BMDNational Center For Research Resources2004–2005
Growth Hormone And Rosiglitazone For Visceral AdiposityNational Institute Of Diabetes And Digestive And Kidney Diseases2004
A5127: PH. II Trial/ Adefovir Dipivoxil/ Tenofovir Disoproxil Fumarate/ HEP B/ HNational Center For Research Resources2004